PHMB OTC
PharmaCom BioVet, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -0.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.1M
52W Range0.000001-0.0001
Volume150,000
Avg Volume136,667
Beta-7.09
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOIra Frohman
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date1999-05-05
Websitepharmacombiovet.com
6040-A Six Forks Road
Raleigh, NC 27609
US
Raleigh, NC 27609
US
919 604 4887
About PharmaCom BioVet, Inc.
PharmaCom BioVet, Inc. (PHMB) operates a network of specialized treatment centers across the United States, dedicated to veterinary oncology. The company's core mission involves advancing bone marrow transplantation and various other innovative cancer therapies for companion animals, particularly those diagnosed with lymphoma, other forms of cancer, and presently incurable conditions. To mitigate suffering in animals battling cancer, PharmaCom BioVet has secured licenses for proprietary medical devices and pharmaceutical compounds. Established in 1995, the company was previously known as ABV Gold Inc. before officially changing its name to PharmaCom BioVet, Inc. in August 2008. Its corporate base is located in Raleigh, North Carolina.
Latest News
No recent news
Recent Insider Trades
No insider trades found